Evidence map›Paper›PMID 23580645›Full record

ArticleThe Journal of biological chemistry2013

Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2.

Nathan Sandbo, Caitlyn Ngam, Elizabeth Torr, Steve Kregel, Jacob Kach, Nickolai Dulin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Expression of serum response factor in the lung mesenchyme is essential for development of pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nathan SandboDivision of Allergy, Pulmonary, and Critical Care, University of Wisconsin, Madison, Wisconsin 53792, USA. nsandbo@medicine.wisc.edu
Caitlyn Ngam
Elizabeth Torr
Steve Kregel
Jacob Kach
Nickolai Dulin
University of Chicago · USUniversity of Wisconsin–Madison · US

Funding

CARDIOVASCULAR PATHOPHYSIOLOGY &BIOCHEMISTRY TRAININGT32HL007237 · NHLBI · UNIVERSITY OF CHICAGO · PI GETZ, GODFREY SHALOM · 1985 to 2011
$5.0M
Novel functions of RGS3R01GM085058 · NIGMS · UNIVERSITY OF CHICAGO · PI DULIN, NICKOLAI O · 2009 to 2012
$1.2M
Signaling Pathways Regulating Serum Response Factor in Pulmonary FibrosisK08HL093367 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SANDBO, NATHAN K · 2009 to 2013
$621k
NHLBI NIH HHS K08 HL093367NHLBI NIH HHS T32 HL007237NHLBI NIH HHS T32HL007237NIGMS NIH HHS R01 GM085058NIGMS NIH HHS R01 GM85058
6 · The paper itself

Abstract

Myofibroblast differentiation plays a critical role in wound healing and in the pathogenesis of fibrosis. We have previously shown that myofibroblast differentiation is mediated by the activity of serum response factor (SRF), which is tightly controlled by the actin polymerization state. In this study, we investigated the role of the microtubule cytoskeleton in modulating myofibroblast phenotype. Treatment of human lung fibroblasts with the microtubule-destabilizing agent, colchicine, resulted in a formation of numerous stress fibers and expression of myofibroblast differentiation marker proteins. These effects of colchicine were independent of Smad signaling but were mediated by Rho signaling and SRF, as they were attenuated by the Rho kinase inhibitor, Y27632, or by the SRF inhibitor, CCG-1423. TGF-β-induced myofibroblast differentiation was not accompanied by gross changes in the microtubule polymerization state. However, microtubule stabilization by paclitaxel attenuated TGF-β-induced myofibroblast differentiation. Paclitaxel had no effect on TGF-β-induced Smad activation and Smad-dependent gene transcription but inhibited actin polymerization, nuclear accumulation of megakaryoblastic leukemia-1 protein, and SRF activation. The microtubule-associated formin, mDIA2, localized to actin stress fibers upon treatment with TGF-β, and paclitaxel prevented this localization. Treatment with the formin inhibitor, SMI formin homology 2 domain, inhibited stress fiber formation and myofibroblast differentiation induced by TGF-β, without affecting Smad-phosphorylation or microtubule polymerization. Together, these data suggest that (a) TGF-β promotes association of mDia2 with actin stress fibers, which further drives stress fiber formation and myofibroblast differentiation, and (b) microtubule polymerization state controls myofibroblast differentiation through the regulation of mDia2 localization.

Indexed as

Adaptor Proteins, Signal TransducingAmidesAnilidesBenzamidesCell DifferentiationCells, CulturedColchicineDNA-Binding ProteinsEnzyme InhibitorsForminsGene Expression RegulationHumansMicrotubule-Associated ProteinsMicrotubulesMyofibroblastsOncogene Proteins, FusionAdaptor Proteins, Signal TransducingAmidesAnilidesBenzamidesCCG 1423ColchicineDIAPH3 protein, humanDNA-Binding ProteinsEnzyme InhibitorsForminsMicrotubule-Associated ProteinsMRTFA protein, humanOncogene Proteins, FusionPaclitaxelPyridinesSerum Response FactorSmad ProteinsSRF protein, humanTrans-ActivatorsTransforming Growth Factor betaTubulin ModulatorsY 27632ActinCytoskeletonFibroblastMicrotubulesMKL1MyofibroblastSRFTransforming Growth Factor Beta (TGFbeta)

Identifiers

PMID23580645
PMCPMC3668708
OpenAlexW1997711954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.